GT Biopharma Inc

Stock Chart, Company Information, and Scan Results

$0.45(as of Jun 12, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

GT Biopharma Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$0.45
Ticker SymbolGTBP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1
CountyUSA
Market Cap$16.1M
EBIDTA-6.8M
10-Day Moving Average0.44
P/E Ratio-0.28
20-Day Moving Average0.43
Forward P/E Ratio17.33
50-Day Moving Average0.39
Earnings per Share-6.46
200-Day Moving Average0.59
Profit Margin-Infinity%
RSI54.45
Shares Outstanding36.1M
ATR0.05
52-Week High3.85
Volume1,432,700
52-Week Low0.26
Most Recent Support Level0.39
Book Value7.6M
Most Recent Resistance Level0.48
P/B Ratio1.79
Upper Keltner0.53
P/S RatioInfinity
Lower Keltner0.33
Debt-to-Equity Ratio0.53
Next Earnings Date08/12/2026
Cash Surplus6.5M
Next Ex-Dividend DateUnknown

GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms. It develops GTB-3650, which is in phase 1 trials that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550, that is in phase 1 dose escalation basket trial that targets B7-H3 on the surface of advanced solid tumors;and GTB-7550, a pre-clinical stage product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.

GT Biopharma Inc In Our Stock Scanner

As of Jun 15, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.